Clinical Trial Update: Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate the efficacy and safety of ABP-671 in adults with chronic kidney disease and hyperuricemia; the study is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• ABP-671

Snippet

Sponsor: Atom Therapeutics Co., Ltd | Conditions: Chronic Kidney Disease | Phase 2 | Status: NOT_YET_RECRUITING